In addition to Kymos, which has been CIR certified for quite some time, our German subsidiary Prolytic has been approved a CIR certification as well. Now your R&D activities (from Early Phase up to Phase IV projects) performed at Kymos and Prolytic are eligible to CIR. You can recover up to 30% of the amount of your project as taxes reduction.
Therefore, if you are planning a research project and you need bioanalytical support with your small molecules, biologics or oligonucleotides or any other analytical services, contact our French representative Boris Benoit (bbenoit@kymos.com).
